CS MEDICA

As an efficient OTC alternative, CS MEDICA is currently first mover to bridge R&D with patent-pending products registered as medical devices with cannabidiol under the pharmaceutical regulation, Medical Device Directive (MDD), now transitioning to Medical Device Regulation (MDR).

For individuals, who seek efficient and cleaner treatments over the counter, CS MEDICA revolutionizes with innovative products and technology within the cannabis and medical industries. From discovery to manufacturing, the company commits to improving people's lives with world-changing products that make a difference.

To secure and capitalize on CS MEDICA's first mover status, the company has entered into an agreement with the financial advisor Kapital Partner regarding the following services:

• Financial strategy
• Sourcing of strategic and financial partners
• Market Relations
• Market compliance

Lone Henriksen, CEO CS MEDICA comments;

"We are happy to announce that we have chosen a new financial advisor who will assist us in our funding of different growth stages, and financial decisions to support us in achieving our purpose and long-term goals."

Kapital Partner A/S
Kapital Partner is a Nordic Growth Market Mentor and Nasdaq Certified Adviser in Denmark and Sweden.  Read more about Kapital Partner at their website.